Venofer (iron sucrose injection, USP)

MAY 01, 2006

American Regent Inc (Shirley, NY) recently received FDA approval for 2 new indications for Venofer. The product was initially approved for use in the treatment of iron deficiency anemia in hemodialysis (HD) patients receiving an erythropoietin. Venofer now also is indicated for the treatment of iron deficiency anemia in peritoneal dialysis (PD) patients receiving an erythropoietin and in nondialysis chronic kidney disease (CKD) patients receiving or not receiving an erythropoietin. The product can be administered via an intravenous push (100-mg [HD] and 200-mg [CKD] doses) or by infusion (300- and 400-mg doses [PD]) depending on the indication. Venofer is available in 100-mg/5-mL single-dose vials. For more information, visit www.venofer.com, or call 800-645-1706.




SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.